Individual and institutional investors, as
well as advisors and analysts are invited to attend a real-time,
interactive presentation on
VirtualInvestorConferences.com
TORONTO, June 22, 2020 /CNW/ - Khiron Life Sciences
Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX:
KHRNF), (Frankfurt: A2JMZC), a
vertically integrated cannabis leader with core operations in
Latin America and Europe, today announced that Alvaro Torres, Khiron CEO and director, and
Chris Naprawa, Khiron Board Chair
and director will present live at VirtualInvestorConferences.com on
June 24th.
DATE: Wednesday, June
24th
TIME: 10:30am ET
LINK: https://www.tinyurl.com/062420KCSAVIC
PARTICIPANTS: Alvaro
Torres, Khiron CEO and director, and Chris Naprawa, Khiron Board Chair and
director
This will be a live, interactive online event where investors
are invited to ask the company questions in real-time. If attendees
are not able to join the event live on the day of the conference,
an archived webcast will also be made available after the
event.
It is recommended that investors pre-register and run the online
system check to expedite participation and receive event
updates.
Learn more about the event at
www.virtualinvestorconferences.com.
Recent Company Highlights
- Achieved first sales in Colombia of low-THC medical cannabis and began
first high-THC medical cannabis sales in Colombia. Only company authorized to sell
medical cannabis in Colombia and
export high-THC cannabis from Colombia
- Received first medical cannabis prescriptions for UK patients
participating in Project Twenty21
- Signed exclusive agreement with Medlive, a distributor serving
3,000 clinics and hospitals in Brazil
- Signed exclusive agreement with Farmacia Universal to
manufacture and distribute Khiron-branded medical cannabis products
in Lima, Peru´s largest city with
8.6 million residents
- Launched teleconsultation service in Colombia giving patients access to health
services and doctors trained to prescribe medical cannabis
- Entered agreement with Tecnologico de Monterrey, a leading Latin American university
in Mexico bringing Khiron´s online
education program to 1,500 physicians and healthcare
practitioners
About Virtual Investor Conferences®
Virtual
Investor Conferences (VIC) is the leading proprietary investor
conference series that provides an interactive forum for
publicly-traded companies to meet and present directly with
investors.
A real-time solution for investor engagement, Virtual Investor
Conferences is part of OTC Market Group's suite of investor
relations services specifically designed for more efficient
Investor Access. Replicating the look and feel of on-site
investor conferences, Virtual Investor Conferences combine
leading-edge conferencing and investor communications capabilities
with a comprehensive global investor audience network.
About Khiron Life Sciences Corp.
Khiron is a vertically integrated global medical and CPG
cannabis leader with core operations in Latin America, and operational activity in
Europe and North
America. Khiron is the first company licensed
in Colombia for the cultivation, production, domestic
distribution, and international export of both low and high THC
medical cannabis products from Colombia to the UK, Peru and Uruguay/Brazil.
Leveraging its first-mover advantage, and patient oriented
approach, Khiron combines global scientific expertise, product
innovation, agricultural infrastructure, wholly-owned medical
clinics, and online doctor education programs to drive prescription
and brand loyalty to address priority medical conditions. Its
Wellbeing unit launched the first branded CBD skincare brand in
Colombia, with Kuida now marketed
in multiple jurisdictions in Latin
America, the US and UK. The Company is led by Co-founder and
Chief Executive Officer, Alvaro
Torres, together with an experienced executive team,
and a Board of Directors that includes Board Chair and capital
markets authority Chris Naprawa,
Audit Committee Chair and Founder of Women Get On Board Deborah
Rosati, and Vicente Fox, the
55th President of Mexico.
Visit Khiron online at www.khiron.ca,
investors.khiron.ca and on Instagram @khironlife
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment analyses,
expectations or statements made by third-parties in respect of
Khiron, its securities, or financial or operating results (as
applicable). Although Khiron believes that the expectations
reflected in forward-looking statements in this press release are
reasonable, such forward-looking statement has been based on
expectations, factors and assumptions concerning future events
which may prove to be inaccurate and are subject to numerous risks
and uncertainties, certain of which are beyond Khiron's control,
including the risk factors discussed in Khiron's Annual Information
Form which is available on Khiron's SEDAR profile
at www.sedar.com. The forward-looking information contained in
this press release is expressly qualified by this cautionary
statement and are made as of the date hereof. Khiron disclaims any
intention and has no obligation or responsibility, except as
required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
Neither the TSXV nor its Regulation Services Provider (as
that term is defined in the policies of the TSXV) accepts
responsibility for the adequacy or accuracy of this press
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/khiron-ceo-and-board-chair-to-participate-in-live-webcast-on-june-24th-301080818.html
SOURCE Khiron Life Sciences Corp.